glp 1 triple agonist retatrutide glp-1 gip glucagon receptor Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight What Is Retatrutide? The Triple
Description
GLP-1 drugs may help with appetite and weight reduction, but they may also create clinically meaningful nutritional side effects, especially in patients with poor baseline diet quality, prolonged use, gastrointestinal side effects, or rapid weight loss
On the other hand, product uptake is through the roof
doi: 10.1055/s-2007-979981 60 SlavinBGOngJMKernPA
This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias
GI side effects broadly in line with injectables
Bottom line Newer diabetes drugs called GLP-1 receptor agonists can promote significant weight loss
